getting pregnant on glp-1 Connection Between Pregnancies and Agonists Reconciling GLP-1s and Pancreatitis

In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)

Safe, inexpensive, and well-tolerated

Honest Care is designed to support you either way

Clinicians should emphasize that GLP-1 medications complement but do not replace evidence-based lipid management with statins

Those warnings include thyroid tumor risk and MEN2 contraindications

Now orforglipron is inching closer to becoming the next oral option to be approved in the U.S